New medical guidelines suggest that millions of adults should consider beginning cholesterol-lowering medications earlier to lessen their chances of heart attacks and strokes.
The updated guidance, published recently by the American College of Cardiology and the American Heart Association, along with nine other medical organizations, highlights the importance of addressing high cholesterol as early as one’s 30s. Early treatment may drastically lower a person’s long-term risk of heart-related events.
One key takeaway from the extensive guideline, which spans 123 pages, is the urgent message: don’t delay action.
According to the new guidelines, individuals as young as 30 should consider statin therapy alongside lifestyle adjustments, like improved diet and regular exercise, particularly if they have an LDL cholesterol level of 160 milligrams per deciliter or higher, a significant family history of early heart disease, or a high 30-year risk of cardiovascular disease.
Dr. Jennifer Haythe, co-director of the Women’s Heart Center at NewYork-Presbyterian/Columbia University, noted the shift from assessing just a 10-year risk to considering a 30-year risk projection. Previously, evaluations focused primarily on short-term risks which were typically low for younger adults.
The updated approach emphasizes that early intervention with cholesterol-lowering medications has solid support from research, indicating that prolonged lower LDL exposure can lead to reduced plaque buildup in arteries.
In the U.S., there are approximately 65 to 70 million individuals aged 30 to 44. Even if only a small portion of them has an LDL level above 160, the number of those who might now meet the criteria for early medication could be substantial.
Statins are among the most commonly prescribed medications for lowering LDL cholesterol, a substance that can accumulate in arteries over time. For those between 30 to 79 years who are at borderline or intermediate risk, the updated guidelines recommend lowering LDL to below 100 milligrams per deciliter to preempt a heart attack or stroke. For the highest risk individuals, the target is even lower—less than 55.
Drs. Pam Morris and Roger Blumenthal, involved with the guidelines, noted that many adults with low 10-year risk but elevated 30-year risk already qualify for statin therapy. Therefore, this new focus might potentially include millions more Americans in the conversation about medication.
This change coincides with mounting evidence indicating that reducing exposure to harmful lipids and lipoproteins over a lifetime can lead to better cardiovascular health outcomes.
The updated guideline also advises healthcare providers to utilize a more modern method for calculating cardiovascular risk in patients aged 30 to 79: the American Heart Association’s online risk calculator, which evaluates both 10-year and 30-year risks. It’s intended as a starting point for conversations between clinicians and patients about treatment options.
Gigi Gari Campos, who experienced a heart attack in her early 30s, reflects that earlier intervention could have changed her situation significantly. She’s now a volunteer advocate for heart health and emphasizes the critical importance of timely treatment.
Campos was aware of her increased cardiovascular risk due to familial hypercholesterolemia—a genetic condition leading to consistently high LDL levels. Yet, conversations with her doctors often revolved around her age, leading to delays in starting treatment. In retrospect, she acknowledges that waiting may not have been the wisest decision.
Her healthcare providers hesitated to prescribe statins due to her being of childbearing age, opting instead for a more cautious approach—delaying treatment until after she had children.
Despite not intending to start a family, Campos felt the urgency to initiate treatment. After discussions with her physician, she began taking statins, which initially lowered her cholesterol but didn’t bring it down to optimal levels before she suffered a heart attack at 34.
On that day, while on a walk with her husband, she felt some distress, not initially realizing the severity of her condition. Although she continued with her day and sought help when the discomfort persisted, an urgent care visit led to an ambulance being called due to an abnormal heart rhythm.
Once at the hospital, she was about to undergo cardiac catheterization when she went into cardiac arrest. Thankfully, the medical team successfully revived her after she lost consciousness.
Afterward, the procedure was completed, and doctors managed to clear blockages within her heart.
Reflecting on that traumatic experience, Campos now advocates for early intervention, believing that had she received timely treatment, her journey would have been drastically different.
With the updated guidelines, millions more could be considered for treatment. Dr. Steven Nissen, a heart health expert, noted that focusing on lifetime risk is critical because LDL cholesterol levels over time are strong indicators of future heart events. He suggests that starting treatment early can simplify management and may not require high-dose statins.
Since her heart attack, Campos has been diligent about her health regimen, consistently taking statins and making lifestyle changes. She has successfully reduced her cholesterol significantly, which brings her comfort and a sense of control over her health.
She emphasizes the importance of education regarding health risks and the necessity to choose treatment options wisely to minimize the chances of a serious heart event. For her, it’s been a matter of life and death.
